These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7425615)

  • 21. Cefpirome (HR810) disk diffusion susceptibility tests: confirmation of interpretive criteria using cefotaxime and cefoperazone-resistant strains and effects of blood supplemented media.
    Jones RN; Barry AL; Thornsberry C
    Diagn Microbiol Infect Dis; 1986 Apr; 4(4):345-9. PubMed ID: 3698547
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of antimicrobial susceptibility of Pseudomonas aeruginosa by disk diffusion and microdilution methods.
    Cox HU; Luther DG
    Am J Vet Res; 1980 Jun; 41(6):906-9. PubMed ID: 6776851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tentative interpretive standards for disk susceptibility tests with moxalactam (LY127935).
    Barry AL; Thornsberry C; Jones RN; Gerlach EH
    Antimicrob Agents Chemother; 1980 Nov; 18(5):716-21. PubMed ID: 6449905
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reliability of a disk diffusion method using semiconfluent growth in the determination of aminoglycoside resistance.
    Huovinen P; Herva E; Katila ML; Klossner ML; Renkonen OV; Toivanen P
    Acta Pathol Microbiol Immunol Scand B; 1986 Jun; 94(3):153-7. PubMed ID: 3739715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of interpretive criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniae.
    Jorgensen JH; Swenson JM; Tenover FC; Barry A; Ferraro MJ; Murray PR; Reller LB
    J Clin Microbiol; 1996 Nov; 34(11):2679-84. PubMed ID: 8897164
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antimicrobial activity of coumermycin and recommendations for disk diffusion tests with 5- and 15-micrograms disks.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1987 May; 7(1):77-82. PubMed ID: 3691036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of netilmicin (SCH 20569) against bacterial isolates from ill children.
    Greenstone G; Hammerberg S; Marks MI
    Chemotherapy; 1978; 24(1):29-33. PubMed ID: 412647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of netilmicin compared with gentamicin, tobramycin, amikacin, and kanamycin.
    Eickhoff TC; Ehret JM
    Antimicrob Agents Chemother; 1977 May; 11(5):791-6. PubMed ID: 879733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compiled data on aminoglycoside, foremost netilmicin susceptibility of bacterial strains.
    Juhlin I; Tunevall G
    Scand J Infect Dis Suppl; 1980; Suppl 23():39-44. PubMed ID: 6782657
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tentative interpretive standards for disk diffusion susceptibility testing with norfloxacin (MK-0366, AM-715).
    Shungu DL; Weinberg E; Gadebusch HH
    Antimicrob Agents Chemother; 1983 Feb; 23(2):256-60. PubMed ID: 6220671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ciprofloxacin disk susceptibility tests: interpretive zone size standards for 5-microgram disks.
    Barry AL; Fass RJ; Anhalt JP; Neu HC; Thornsberry C; Tilton RC; Painter BG; Washington JA
    J Clin Microbiol; 1985 Jun; 21(6):880-3. PubMed ID: 3159749
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pseudomonas aeruginosa resistant to aminoglycosides: an assessment of the currently used methods of disk diffusion and dilution susceptibility.
    Ismaeel NA
    Microbios; 1991; 66(268-269):197-204. PubMed ID: 1907714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro comparison of gentamicin and netilmicin including a regression line for netilmicin.
    Bang J; Mortensen I; Bentzon MW
    Scand J Infect Dis Suppl; 1980; Suppl 23():34-8. PubMed ID: 6782656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The in vitro activity of gentamicin, tobramycin and netilmicin against 500 clinical isolates of bacteria. A comparative study using three different test media.
    Digranes A; Dibb WL; Benonisen E; Ostervold B
    Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):135-9. PubMed ID: 6408889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro susceptibility of gentamicin-resistant Enterobacteriaceae and Pseudomonas aeruginosa to netilmicin and selected aminoglycoside antibiotics.
    Meyer RD; Draus LL; Pasieczinik KA
    Antimicrob Agents Chemother; 1976 Oct; 10(4):677-81. PubMed ID: 825036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of netilmicin and cefotaxime compared to that of other aminoglycosides.
    Shah PM; Belve V
    Methods Find Exp Clin Pharmacol; 1979 Dec; 1(5):285-8. PubMed ID: 552591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the AutoMicrobic system for susceptibility testing of aminoglycosides and gram-negative bacilli.
    Hindler JA; Bruckner DA
    J Clin Microbiol; 1987 Mar; 25(3):546-50. PubMed ID: 3571458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ceftazidime: in vitro comparison with cephalothin, cefuroxime, and netilmicin. A Norwegian study.
    Digranes A; Dibb WL; Benonisen E
    Chemotherapy; 1984; 30(2):113-8. PubMed ID: 6365480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro comparison of netilmicin, a semisynthetic derivative of sisomicin, and four other aminoglycoside antibiotics.
    Kabins SA; Nathan C; Cohen S
    Antimicrob Agents Chemother; 1976 Jul; 10(1):139-45. PubMed ID: 825021
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Susceptibility testing of carumonam: interpretive criteria for 30-microgram disk tests and quality control guidelines for disk diffusion and broth microdilution methods.
    Jones RN; Barry AL
    J Clin Microbiol; 1987 Nov; 25(11):2243-6. PubMed ID: 3693552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.